221 related articles for article (PubMed ID: 35219354)
1. Emerging Roles of Long Non-coding RNAs as Novel Biomarkers in the Diagnosis and Prognosis of Prostate Cancer.
Kan Y; Li B; Yang D; Liu Y; Liu J; Yang C; Mao L
Discov Med; 2021; 32(165):29-37. PubMed ID: 35219354
[TBL] [Abstract][Full Text] [Related]
2. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNAs in prostate cancer: Functional roles and clinical implications.
Xu YH; Deng JL; Wang G; Zhu YS
Cancer Lett; 2019 Nov; 464():37-55. PubMed ID: 31465841
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNAs and prostate cancer.
Misawa A; Takayama KI; Inoue S
Cancer Sci; 2017 Nov; 108(11):2107-2114. PubMed ID: 28796922
[TBL] [Abstract][Full Text] [Related]
5. The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
Zheng J; Zhao S; He X; Zheng Z; Bai W; Duan Y; Cheng S; Wang J; Liu X; Zhang G
Biochem Biophys Res Commun; 2016 Nov; 480(4):508-514. PubMed ID: 27558961
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA: A newly deciphered "code" in prostate cancer.
Zhang A; Zhang J; Kaipainen A; Lucas JM; Yang H
Cancer Lett; 2016 Jun; 375(2):323-330. PubMed ID: 26965999
[TBL] [Abstract][Full Text] [Related]
7. Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
Smolle MA; Bauernhofer T; Pummer K; Calin GA; Pichler M
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241429
[TBL] [Abstract][Full Text] [Related]
8. Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding star.
Xu T; Lin CM; Cheng SQ; Min J; Li L; Meng XM; Huang C; Zhang L; Deng ZY; Li J
Mol Cancer; 2018 Jul; 17(1):103. PubMed ID: 30037351
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNAs in prostate cancer: Biological and clinical implications.
Das R; Feng FY; Selth LA
Mol Cell Endocrinol; 2019 Jan; 480():142-152. PubMed ID: 30391670
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNAs in prostate cancer: overview and clinical implications.
Malik B; Feng FY
Asian J Androl; 2016; 18(4):568-74. PubMed ID: 27072044
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNAs and prostate carcinogenesis: the missing 'linc'?
Walsh AL; Tuzova AV; Bolton EM; Lynch TH; Perry AS
Trends Mol Med; 2014 Aug; 20(8):428-36. PubMed ID: 24836411
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNAs and their potential impact on diagnosis, prognosis, and therapy in prostate cancer: racial, ethnic, and geographical considerations.
Morgan R; da Silveira WA; Kelly RC; Overton I; Allott EH; Hardiman G
Expert Rev Mol Diagn; 2021 Dec; 21(12):1257-1271. PubMed ID: 34666586
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
[TBL] [Abstract][Full Text] [Related]
14. Potential of long non-coding RNAs in cancer patients: From biomarkers to therapeutic targets.
Chandra Gupta S; Nandan Tripathi Y
Int J Cancer; 2017 May; 140(9):1955-1967. PubMed ID: 27925173
[TBL] [Abstract][Full Text] [Related]
15. Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer.
Wan X; Huang W; Yang S; Zhang Y; Pu H; Fu F; Huang Y; Wu H; Li T; Li Y
Oncotarget; 2016 Sep; 7(37):60503-60518. PubMed ID: 27556357
[TBL] [Abstract][Full Text] [Related]
16. Identification of a long non-coding RNA as a novel biomarker and potential therapeutic target for metastatic prostate cancer.
Crea F; Watahiki A; Quagliata L; Xue H; Pikor L; Parolia A; Wang Y; Lin D; Lam WL; Farrar WL; Isogai T; Morant R; Castori-Eppenberger S; Chi KN; Wang Y; Helgason CD
Oncotarget; 2014 Feb; 5(3):764-74. PubMed ID: 24519926
[TBL] [Abstract][Full Text] [Related]
17. eRNAs and Superenhancer lncRNAs Are Functional in Human Prostate Cancer.
Zhang X; Pang P; Jiang M; Cao Q; Li H; Xu Y; Li Y; Chen X; Han J
Dis Markers; 2020; 2020():8847986. PubMed ID: 33029258
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.
Xu S; Yi XM; Tang CP; Ge JP; Zhang ZY; Zhou WQ
Oncol Rep; 2016 Jul; 36(1):10-22. PubMed ID: 27176634
[TBL] [Abstract][Full Text] [Related]
19. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
Wang YH; Ji J; Wang BC; Chen H; Yang ZH; Wang K; Luo CL; Zhang WW; Wang FB; Zhang XL
Cell Physiol Biochem; 2018; 46(2):532-545. PubMed ID: 29614511
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.
Qiu L; Tang Q; Li G; Chen K
Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]